Prognostic value of soluble angiopoietin-2 and soluble Tie-2 in Egyptian patients with acute myeloid leukemia

OBJECTIVE: Angiogenesis plays a critical role in the development and growth of solid tumors and hematologic malignancies. The system involving angiopoietin-2 [Ang-2] and its receptor Tie-2 appears to play an important role in tumor angiogenesis and in the biology of hematological and non-hematologic...

Full description

Bibliographic Details
Main Authors: Mohamed A. Attia, Sahar M. Hazzaa, Salwa A. Essa, Mahmoud F. Seleim
Format: Article
Language:English
Published: Galenos Publishing House 2010-12-01
Series:Turkish Journal of Hematology
Subjects:
Online Access:https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-87059
_version_ 1797909184837058560
author Mohamed A. Attia
Sahar M. Hazzaa
Salwa A. Essa
Mahmoud F. Seleim
author_facet Mohamed A. Attia
Sahar M. Hazzaa
Salwa A. Essa
Mahmoud F. Seleim
author_sort Mohamed A. Attia
collection DOAJ
description OBJECTIVE: Angiogenesis plays a critical role in the development and growth of solid tumors and hematologic malignancies. The system involving angiopoietin-2 [Ang-2] and its receptor Tie-2 appears to play an important role in tumor angiogenesis and in the biology of hematological and non-hematological malignancies. We evaluated the levels of soluble (s)Ang-2 and sTie-2 in acute myeloid leukemia (AML) patients and investigated the impact of their circulating levels on the overall survival in those patients. METHODS: Ang-2 and Tie-2 were measured in plasma samples from AML patients and controls using enzyme-linked immunosorbent assay (ELISA). RESULTS: The levels of sAng-2 and sTie-2 were significantly higher in AML patients (2382.1+-1586.1 pg/ml and 6.74+-3.47 ng/ml, respectively) than in controls (649.5+-402.6 pg/ml and 2.63+-0.57 ng/ml, respectively; p<0.01). AML patients with high levels of sAng-2 and sTie-2 (&#8805;2500 pg/ml and &#8805;8 ng/ml, respectively) had significantly shorter overall survival than those patients with low levels (<2500 pg/ml and <8 ng/ml, respectively). CONCLUSION: The results of our study demonstrated the prognostic significance of circulating sAng-2 and sTie-2 in AML patients. Modulation of the angiopoietin / Tie-2 axis may be a promising approach to improve the outcome in those patients.
first_indexed 2024-04-10T11:04:26Z
format Article
id doaj.art-5ca5db76d2ed4c0f8344a5ba960ade41
institution Directory Open Access Journal
issn 1308-5263
language English
last_indexed 2024-04-10T11:04:26Z
publishDate 2010-12-01
publisher Galenos Publishing House
record_format Article
series Turkish Journal of Hematology
spelling doaj.art-5ca5db76d2ed4c0f8344a5ba960ade412023-02-15T16:19:31ZengGalenos Publishing HouseTurkish Journal of Hematology1308-52632010-12-0127428228810.5152/tjh.2010.50TJH-87059Prognostic value of soluble angiopoietin-2 and soluble Tie-2 in Egyptian patients with acute myeloid leukemiaMohamed A. Attia0Sahar M. Hazzaa1Salwa A. Essa2Mahmoud F. Seleim3Department Of Clinical Pathology, Tanta University Faculty Of Medicine, Tanta, EgyptDepartment Of Clinical Pathology, Tanta University Faculty Of Medicine, Tanta, EgyptDepartment Of Clinical Pathology, Tanta University Faculty Of Medicine, Tanta, EgyptDepartment Of Internal Medicine, Tanta University Faculty Of Medicine, Tanta, EgyptOBJECTIVE: Angiogenesis plays a critical role in the development and growth of solid tumors and hematologic malignancies. The system involving angiopoietin-2 [Ang-2] and its receptor Tie-2 appears to play an important role in tumor angiogenesis and in the biology of hematological and non-hematological malignancies. We evaluated the levels of soluble (s)Ang-2 and sTie-2 in acute myeloid leukemia (AML) patients and investigated the impact of their circulating levels on the overall survival in those patients. METHODS: Ang-2 and Tie-2 were measured in plasma samples from AML patients and controls using enzyme-linked immunosorbent assay (ELISA). RESULTS: The levels of sAng-2 and sTie-2 were significantly higher in AML patients (2382.1+-1586.1 pg/ml and 6.74+-3.47 ng/ml, respectively) than in controls (649.5+-402.6 pg/ml and 2.63+-0.57 ng/ml, respectively; p<0.01). AML patients with high levels of sAng-2 and sTie-2 (&#8805;2500 pg/ml and &#8805;8 ng/ml, respectively) had significantly shorter overall survival than those patients with low levels (<2500 pg/ml and <8 ng/ml, respectively). CONCLUSION: The results of our study demonstrated the prognostic significance of circulating sAng-2 and sTie-2 in AML patients. Modulation of the angiopoietin / Tie-2 axis may be a promising approach to improve the outcome in those patients.https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-87059ang-2tie-2amlelisa
spellingShingle Mohamed A. Attia
Sahar M. Hazzaa
Salwa A. Essa
Mahmoud F. Seleim
Prognostic value of soluble angiopoietin-2 and soluble Tie-2 in Egyptian patients with acute myeloid leukemia
Turkish Journal of Hematology
ang-2
tie-2
aml
elisa
title Prognostic value of soluble angiopoietin-2 and soluble Tie-2 in Egyptian patients with acute myeloid leukemia
title_full Prognostic value of soluble angiopoietin-2 and soluble Tie-2 in Egyptian patients with acute myeloid leukemia
title_fullStr Prognostic value of soluble angiopoietin-2 and soluble Tie-2 in Egyptian patients with acute myeloid leukemia
title_full_unstemmed Prognostic value of soluble angiopoietin-2 and soluble Tie-2 in Egyptian patients with acute myeloid leukemia
title_short Prognostic value of soluble angiopoietin-2 and soluble Tie-2 in Egyptian patients with acute myeloid leukemia
title_sort prognostic value of soluble angiopoietin 2 and soluble tie 2 in egyptian patients with acute myeloid leukemia
topic ang-2
tie-2
aml
elisa
url https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-87059
work_keys_str_mv AT mohamedaattia prognosticvalueofsolubleangiopoietin2andsolubletie2inegyptianpatientswithacutemyeloidleukemia
AT saharmhazzaa prognosticvalueofsolubleangiopoietin2andsolubletie2inegyptianpatientswithacutemyeloidleukemia
AT salwaaessa prognosticvalueofsolubleangiopoietin2andsolubletie2inegyptianpatientswithacutemyeloidleukemia
AT mahmoudfseleim prognosticvalueofsolubleangiopoietin2andsolubletie2inegyptianpatientswithacutemyeloidleukemia